These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38339118)

  • 1. AAV-RPGR Gene Therapy Rescues Opsin Mislocalisation in a Human Retinal Organoid Model of
    Sladen PE; Naeem A; Adefila-Ideozu T; Vermeule T; Busson SL; Michaelides M; Naylor S; Forbes A; Lane A; Georgiadis A
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa.
    Fischer MD; McClements ME; Martinez-Fernandez de la Camara C; Bellingrath JS; Dauletbekov D; Ramsden SC; Hickey DG; Barnard AR; MacLaren RE
    Mol Ther; 2017 Aug; 25(8):1854-1865. PubMed ID: 28549772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelsolin dysfunction causes photoreceptor loss in induced pluripotent cell and animal retinitis pigmentosa models.
    Megaw R; Abu-Arafeh H; Jungnickel M; Mellough C; Gurniak C; Witke W; Zhang W; Khanna H; Mill P; Dhillon B; Wright AF; Lako M; Ffrench-Constant C
    Nat Commun; 2017 Aug; 8(1):271. PubMed ID: 28814713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice.
    Song C; Conlon TJ; Deng WT; Coleman KE; Zhu P; Plummer C; Mandapati S; Van Hoosear M; Green KB; Sonnentag P; Sharma AK; Timmers A; Robinson PM; Knop DR; Hauswirth WW; Chulay JD; Shearman MS; Ye GJ
    Hum Gene Ther Clin Dev; 2018 Dec; 29(4):188-197. PubMed ID: 30280954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of RPGR glutamylation underlies the pathogenic mechanism of retinal dystrophy caused by TTLL5 mutations.
    Sun X; Park JH; Gumerson J; Wu Z; Swaroop A; Qian H; Roll-Mecak A; Li T
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E2925-34. PubMed ID: 27162334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration.
    Wu Z; Hiriyanna S; Qian H; Mookherjee S; Campos MM; Gao C; Fariss R; Sieving PA; Li T; Colosi P; Swaroop A
    Hum Mol Genet; 2015 Jul; 24(14):3956-70. PubMed ID: 25877300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose Range Finding Studies with Two
    Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS
    Hum Gene Ther; 2020 Jul; 31(13-14):743-755. PubMed ID: 32414297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
    Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
    Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15.
    Thompson DA; Khan NW; Othman MI; Chang B; Jia L; Grahek G; Wu Z; Hiriyanna S; Nellissery J; Li T; Khanna H; Colosi P; Swaroop A; Heckenlively JR
    PLoS One; 2012; 7(5):e35865. PubMed ID: 22563472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
    Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
    Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.
    Mookherjee S; Hiriyanna S; Kaneshiro K; Li L; Li Y; Li W; Qian H; Li T; Khanna H; Colosi P; Swaroop A; Wu Z
    Hum Mol Genet; 2015 Nov; 24(22):6446-58. PubMed ID: 26358772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single, abbreviated RPGR-ORF15 variant reconstitutes RPGR function in vivo.
    Hong DH; Pawlyk BS; Adamian M; Sandberg MA; Li T
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):435-41. PubMed ID: 15671266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Molecularly Stable Gene Therapy Vector for the Treatment of
    Giacalone JC; Andorf JL; Zhang Q; Burnight ER; Ochoa D; Reutzel AJ; Collins MM; Sheffield VC; Mullins RF; Han IC; Stone EM; Tucker BA
    Hum Gene Ther; 2019 Aug; 30(8):967-974. PubMed ID: 31106594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Strategies for RPGR Gene Therapy.
    Cehajic Kapetanovic J; McClements ME; Martinez-Fernandez de la Camara C; MacLaren RE
    Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31487940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa.
    Martinez-Fernandez de la Camara C; Cehajic-Kapetanovic J; MacLaren RE
    Expert Opin Emerg Drugs; 2022 Dec; 27(4):431-443. PubMed ID: 36562395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa.
    Beltran WA; Cideciyan AV; Lewin AS; Iwabe S; Khanna H; Sumaroka A; Chiodo VA; Fajardo DS; Román AJ; Deng WT; Swider M; Alemán TS; Boye SL; Genini S; Swaroop A; Hauswirth WW; Jacobson SG; Aguirre GD
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2132-7. PubMed ID: 22308428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids.
    Lane A; Jovanovic K; Shortall C; Ottaviani D; Panes AB; Schwarz N; Guarascio R; Hayes MJ; Palfi A; Chadderton N; Farrar GJ; Hardcastle AJ; Cheetham ME
    Stem Cell Reports; 2020 Jul; 15(1):67-79. PubMed ID: 32531192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing.
    Gumerson JD; Alsufyani A; Yu W; Lei J; Sun X; Dong L; Wu Z; Li T
    Gene Ther; 2022 Feb; 29(1-2):81-93. PubMed ID: 34257417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Correction Reverses Ciliopathy and Photoreceptor Loss in iPSC-Derived Retinal Organoids from Retinitis Pigmentosa Patients.
    Deng WL; Gao ML; Lei XL; Lv JN; Zhao H; He KW; Xia XX; Li LY; Chen YC; Li YP; Pan D; Xue T; Jin ZB
    Stem Cell Reports; 2018 Apr; 10(4):1267-1281. PubMed ID: 29526738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosa.
    Pawlyk BS; Bulgakov OV; Sun X; Adamian M; Shu X; Smith AJ; Berson EL; Ali RR; Khani S; Wright AF; Sandberg MA; Li T
    Gene Ther; 2016 Feb; 23(2):196-204. PubMed ID: 26348595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.